Used in pharmaceutical synthesis as an intermediate for developing bioactive molecules, particularly in the production of central nervous system agents. Its structure supports the design of compounds with neurological activity, including potential use in antidepressants and receptor modulators. Commonly employed in medicinal chemistry for scaffold development due to its piperidine ring substituted at the 4-position with a tetrahydrofuran-3-yl moiety, enhancing binding selectivity. Also utilized in the preparation of novel drug candidates targeting pain management and cognitive disorders.